Viewed altogether, the data indicate that the effects of CCL5 treatment on the different breast cancer cell types are associated with enhanced metabolic activity that would support the energy and biosynthetic demands of tumour cell proliferation, migration and invasion. The gene discussed is CCL5; the disease is neoplasm.